Cleared Traditional

K050697 - MODEL DS-1901 DIGITAL BLOOD PRESSURE MONITOR

K050697 is an FDA 510(k) clearance for MODEL DS-1901 DIGITAL BLOOD PRESSURE MO..., manufactured by Nihon Seimitsu Sokki Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 7-day FDA review.

K050697 · Nihon Seimitsu Sokki Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2005
Decision
7d
Days
Class 2
Risk

K050697 is an FDA 510(k) clearance for the MODEL DS-1901 DIGITAL BLOOD PRESSURE MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Nihon Seimitsu Sokki Co., Ltd. (Flemington, US). The FDA issued a Cleared decision on March 25, 2005 after a review of 7 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nihon Seimitsu Sokki Co., Ltd. devices

FDA 510(k) Submission Details - K050697

510(k) Number K050697 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 2005
Decision Date March 25, 2005
Days to Decision 7 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 125d · This submission: 7d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Kema Quality B.V.
PATRICIA L MURPHY

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 841
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K050697.
MS-753 MARS INFLATE-READ BLOOD PRESSURE MONITOR
K050040 · Mars Medical Products · Mar 2005
HL168JP
K050249 · Health & Life Co., Ltd. · Mar 2005
MS-930 MARS INFLATE-READ BLOOD PRESSURE MONITOR
K050039 · Mars Medical Products · Mar 2005
KD-575 MEMORY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K042418 · Kodon(Tianjin)Electronic&Electrical Apparatus Co., · Mar 2005
DIASYS INTEGRA II
K042109 · Novacor France · Mar 2005
AMPLIEF WRIST BLOOD PRESSURE MONITOR, MODEL M600
K050413 · Amplife Corporation · Mar 2005